Adenosine by aortic flush fails to augment the brain preservation effect of mild hypothermia during exsanguination cardiac arrest in dogs - An exploratory study

Resuscitation

Volumn 44, Issue 1, 2000, Pages 47-59

  Woods, Randy J ^a   Prueckner, Stephan ^a   Safar, Peter ^a   Takasu, Akira ^a   Tisherman, Samuel A ^a   Jackson, Edwin K ^a   Radovsky, Ann ^a   Kochanek, Patrick ^a   Behringer, Wilhelm ^a   Stezoski, S William ^a   Hans, Rochelle ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adenosine; Brain ischemia; Cardiac arrest; Hemorrhage; Hypothermia; Routes of drug administration

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DOG; HEART ARREST; HYPOTHERMIA; MALE; NONHUMAN; PRESERVATION; PRIORITY JOURNAL; RESUSCITATION;

ADENOSINE; ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DOGS; HEART ARREST; HEMODYNAMIC PROCESSES; HYPOTHERMIA, INDUCED; INFUSIONS, INTRA-ARTERIAL; MALE; REFERENCE VALUES; SHOCK, HEMORRHAGIC; SURVIVAL RATE; VASODILATOR AGENTS;

EID: 0034160049     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(99)00164-1     Document Type: Article

References (61)

1. Bellamy R.F. The causes of death in conventional land warfare: implications for combat casualty care research. Milit. Med. 149:1984;55-62.
2. Bellamy R., Safar P., Tisherman S.A., Basford R., Bruttig S.P., Capone A., Dubick M.A., Ernster L., Hattler B.G. Jr, Hochachka P., Klain M., Kochanek P.M., Kofke W.A., Lancaster J.R., McGowan F.X., Oeltgen P.R., Severinghaus J.W., Taylor M.J., Zar H. Suspended animation for delayed resuscitation. Crit. Care Med. 24/S:1996;S24-S47.
3. Safar P. Resuscitation from clinical death: patho-physiologic limits and therapeutic potentials. Crit. Care Med. 16:1988;923-941.
4. Bigelow W.G., Lindsay W.K., Greenwood W.F. Hypothermia, its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperature. Ann. Surg. 132:1950;849-866.
5. Tisherman S.A., Safar P., Radovsky A., Peitzman A., Sterz F., Kuboyama K. Therapeutic deep hypothermic circulatory arrest in dogs: a resuscitation modality for hemorrhagic shock with `irreparable' injury. J. Trauma. 30:1990;836-847.
6. Tisherman S.A., Safar P., Radovsky A., Peitzman A., Marrone G., Kuboyama K., Weinrauch V. Profound hypothermia (<10°C) compared with deep hypothermia (15°C) improves neurologic outcome in dogs after 2 h circulatory arrest induced to enable resuscitative surgery. J. Trauma. 31:1991;1051-1062.
7. Capone A., Safar P., Radovsky A., Wang Y., Peitzman A., Tisherman S.A. Complete recovery after normothermic hemorrhagic shock and profound hypothermic circulatory arrest of 60 min in dogs. J. Trauma. 40:1996;388-394.
8. Connolly J.E., Roy A., Guernsey J.M., Stemmer E.A. Bloodless surgery by means of profound hypothermia and circulatory arrest: effect on brain and heart. Ann. Surg. 162:1965;724-737.
9. Safar P. Resuscitation of the ischemic brain. Albin M.S. Textbook of Neuroanesthesia with Neurosurgical and Neuroscience Perspectives. 1997;557-593 McGraw-Hill, New York.
10. Safar P., Abramson N.S., Angelos M., Cantadore R., Leonov Y., Levine R., Pretto E., Reich H., Sterz F., Stezoski S.W., Tisherman S. Emergency cardiopulmonary bypass for resuscitation from prolonged cardiac arrest. Am. J. Emerg. Med. 8:1990;55-67.
11. Woods R., Safar P., Takasu A., Prueckner S., Stezoski S.A., Stezoski J., Tisherman S.A. Hypothermic aortic arch flush for preservation during exsanguination cardiac arrest of 15 minutes in dogs. J. Trauma. 47:1999;1028-1038.
12. Prueckner S., Woods R.J., Safar P., Takasu A., Stezoski S.W., Radovsky A., Tisherman S.A. Mild hypothermic aortic arch flush improves neurologic outcome from exsanguination cardiac arrest in dogs. Crit. Care Med. 27:1999;A105. Abstract.
13. Behringer W., Prueckner S., Tisherman S.A., Safar P., Radovsky A., Stezoski W., Henchier J. Outcome model in dogs of exsanguination cardiac arrest (CA) of 20 min with hypothermic aortic arch flush for cerebral preservation. Acad. Emerg. Med. 6:1999;251. Abstract.
14. Behringer W., Prueckner S., Kentner R.A., Tisherman S.A., Radovsky A., Henchir J., Hans R., Safar P. Complete cerebral recovery after 30-min cardiac arrest (CA) in dogs by preservative cold aortic flush. Circulation. 100/18:1999;1649. Abstract.
15. Tisherman S.A., Safar P., Abramson N.S., Marrone G., Kormos R., Stein K., Peitzman A., Paris P. Feasibility of emergency cardiopulmonary bypass for resuscitation from CPR-resistant cardiac arrest - a preliminary report. Ann. Emerg. Med. 20:1991;491. Abstract.
16. Taylor M.J., Bailes J.E., Elrifai A.M., Shih S.R., Teeple E., Leavitt M.L., Baust J.G., Maroon J.C. A new solution for life without blood: asanguinous low flow perfusion of a whole body perfusate during 3 h of cardiac arrest and profound hypothermia. Circulation. 91:1995;431-444.
17. Tisherman S.A., Safar P., Sterz F., Leonov Y., Oku K., Stezoski W. Exsanguination cardiac arrest in dogs: pathophysiology of dying. Ann. Emerg. Med. 18:1989;460. Abstract 116.
18. Tisherman S.A., Safar P., Sterz F., Leonov Y., Oku K., Stezoski W. Exsanguination versus ventricular fibrillation cardiac arrest in dogs: comparison of neurologic outcome - preliminary data. Ann. Emerg. Med. 18:1989;460. Abstract 117.
19. Woods R.J., Prueckner S., Safar P., Takasu A., Tisherman S.A., Jackson E.K., Radovsky A., Kochanek P., Stezoski S.W., Stezoski J. Adenosine by aortic flush fails to augment the brain preservation effect of mild hypothermia during exsanguination cardiac arrest in dogs. Crit. Care Med. 27:1999;A106.
20. Miller L.P., Hsu C. Therapeutic potential for adenosine receptor activation in ischemic brain injury. J. Neurotrauma. 9(Suppl 2):1992;S563-S577.
21. Von Lubitz D.K.J.E., Lin R.C.S., Melman N., Ji X.D., Carter M.F., Jacobson K.A. Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia. Eur. J. Pharmacol. 256:1994;161-167.
22. Forman M.B., Velasco C.E., Jackson E.K. Adenosine attenuates reperfusion injury following regional myocardial ischaemia. Cardiovasc. Res. 27:1993;9-17.
23. Maggirwar S.B., Dhanraj D.N., Somani S.M., Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defence system. Biochem. Biophys. Res. Commun. 201:1994;508-515.
24. Vinten-Johansen J., Zhao Z.Q., Sato H. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy. Ann. Thorac. Surg. 60:1995;852-857.
25. Hudspeth D.A., Nakanishi K., Vinten-Johansen J., Zhao Z.Q., McGee D.S., Williams M.W., Hammon J.W. Jr Adenosine in blood cardioplegia prevents postischemic dysfunction in ischemically injured hearts. Ann. Thorac. Surg. 58:1994;1637-1644.
26. Pitarys C.J., Virmani R., Vildibill H.D. Jr, Jackson E.K., Forman M.B. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation. 83:1991;237-247.
27. Grisham M.B., Hernandez L.A., Granger D.N. Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am. J. Physiol. 257(5(Pt 2)):1989;H1334-H1339.
28. Kaminski P.M., Proctor K.G. Actions of adenosine on nitro blue tetrazolium deposition and surface pH during intestinal reperfusion injury. Circ. Res. 66:1990;1713-1719.
29. Walus K.M., Fondacaro J.D., Jacobson E.D. Effects of adenosine and its derivatives on the canine intestinal vasculature. Gastroenterology. 82:1981;327-334.
30. Marts B.C., Baudendistel L.J., Naunheim K.S., Dahms T.E. Protective effect of 2-chloro-adenosine on lung ischemia reperfusion injury. J. Surg. Res. 54:1993;523-529.
31. Bell M., Kochanek P.M., Carcillo J.A., Mi Z., Schiding J.K., Wisniewski S.R., Clark R.S.B., Dixon C.E., Marion D.W., Jackson E. Interstitial adenosine, inosine and hypoxanthine are increased after experimental traumatic brain injury in the rat. J. Neurotrauma. 15:1998;163-170.
32. Bell M.J., Kochanek P.M., Carcillo J.A., Mi Z., Schiding J.K., Wisniewski S.R., Clark R.S.B., Dixon C.E., Marion D.W., Jackson E. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J. Neurotrauma. 15:1998;163-170.
33. Pardridge W.M., Yoshikawa T., Kang Y.-S., Miller L.P. Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. J. Pharmacol. Exper. Ther. 268:1994;14-18.
34. Mahaffey K.W., Puma J.A., Barbagelata A., Casas C.A., Lambe L., Orlandi C., Gibbons R.J., Califf R.M., Granger C.B. Does adenosine in conjunction with thrombolysis reduce infarct size? Results from the controlled, randomized AMISTAD trial. Circulation. 96:1997;206-207.
35. Daly J.W., Jacobson K.A. Adenosine receptors: selective agonists and antagonists. Belardinelli L., Peleg A. Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. 1995;157-166 Kluwer, Boston.
36. Sterz F., Leonov Y., Safar P., Johnson D., Oku K., Tisherman S., Latchaw R., Obrist W., Stezoski S.W., Hecht S., Tarr R., Janosky J.E. Multifocal cerebral blood flow by Xe-CT and global cerebral metabolism after prolonged cardiac arrest in dogs: reperfusion with open-chest CPR or cardiopulmonary bypass. Resuscitation. 24:1992;27-47.
37. Nemoto E.M., Bleyaert A.L., Stezoski S.W., Moossy J., Rao G.R., Safar P. Global brain ischemia: a reproducible monkey model. Stroke. 8/5:1977;558-564.
38. Safar P., Gisvold S.E., Vaagenes P., Hendrickx H.H.L., Bar-Joseph G., Bircher N., Stezoski W., Alexander H. Long-term animal models for the study of global brain ischemia. Wauquier A. et al. Protection of Tissues Against Hypoxia. 1982;147-170 Elsevier, Amsterdam.
39. Vaagenes P., Cantadore R., Safar P., Moossy J., Rao G., Diven W., Alexander H., Stezoski W. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs. Crit. Care Med. 12:1984;846-855.
40. Leonov Y., Sterz F., Safar P., Radovsky A., Oku K., Tisherman S., Stezoski S.W. Mild cerebral hypothermia during and after cardiac arrest improves neurologic outcome in dogs. J. Cereb. Blood Flow Metab. 10:1990;57-70.
41. Safar P., Xiao F., Radovsky A., Tanigawa K., Ebmeyer U., Bircher N., Alexander H., Stezoski S.W. Improved cerebral resuscitation from cardiac arrest in dogs with mild hypothermia plus blood flow promotion. Stroke. 27:1996;105-113.
42. Radovsky A., Safar P., Sterz F., Leonov Y., Reich H., Kuboyama K. Regional prevalence and distribution of ischemic neurons in dog brains 96 h after cardiac arrest of 0-20 min. Stroke. 26:1995;2127-2134.
43. Von Lubitz D.K.J.E. Adenosine and acute treatment of cerebral ischemia and stroke - put out more flags. Jacobson K.A., Jarvis M.F. Purinergic Approaches in Experimental Therapeutics. 1997;449-470 Wiley, New York.
44. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Adenosine and brain ischemia. Cereb. Brain Metab. Rev. 4:1992;346-369.
45. Evans M.C., Swan J.H., Meldrum B.S. An adenosine analogue, 2-chloro-adenosine, protects against long term development of ischaemic cell loss in the rat hippocampus. Neurosci. Lett. 83:1987;287-292.
46. 2+influx. Br. J. Pharmcol. 98:1989;225-235.
47. Jiang N., Kowaluk E.A., Lee C.H., Mazdiyasni H., Chopp M. Adenosine kinase inhibition protects brain against transient focal ischemia in rats. Eur. J. Pharmacol. 320:1997;131-137.
48. Miller L.P., Jelovich L.A., Yao L., DaRe J., Ugarkar B., Foster A.C. Pre- and peristroke treatment with the adenosine kinase inhibitor, 5′-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats. Neurosci. Lett. 220:1996;73-76.
49. Heron A., Lekieffre D., Le Peillet E., Lasbennes F., Seylaz J., Plotkine M., Boulu R.G. Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia. Brain Res. 641:1994;217-224.
50. O'Regan M.H., Simpson R.E., Perkins L.M., Phillis J.W. The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci. Lett. 138:1992;169-172.
51. Brodie M.S., Lee K., Fredholm B.B., Stahle L., Dunwiddie T.V. Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action. Brain Res. 415:1987;323-330.
52. Robertson C.L., Hendrich K.S., Kochanek P.M., Jackson E.K., Melick J.A., Graham S.H., Marion D.W., Williams D.S., Ho C. Assessment of 2-chloro-adenosine treatment after experimental traumatic brain injury in the rat using arterial spin-labeled MRI. Proc. Int. Soc. Magn. Reson. Med. 7:1999;896. Abstract.
53. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5-13.
54. Born G.V.R., Cross M.J. The aggregation of blood platelets. J. Physiol. (Lond.). 168:1963;178-195.
55. Hossmann V., Hossmann K.A., Takagi S. Effect of intravascular platelet aggregation on blood recirculation following prolonged ischemia of the cat brain. J. Neurol. 222:1980;159-170.
56. Von Lubitz D.K. Adenosine A3 receptor and brain: a culprit, a hero, or merely yet another receptor? Ann. N.Y. Acad. Sci. 825:1997;49-67.
57. Von Lubitz D.K., Lin R.C., Popik P. et al. Adenosine A3 receptor stimulation and cerebral ischemia. Eur. J. Pharmacol. 263:1994;59-67.
58. Behringer W., Prueckner S., Tisherman S.A., Radovsky A. Thiopental (TH) by aortic flush (AAF) for cerebral preservation in a 20 min exsanguination cardiac arrest (CA) exploratory dog study. Anesthesiology. 91:1999;A251. Abstract.
59. Behringer W., Prueckner S., Safar P., Tisherman S.A., Radovsky A., Stezoski W., Bicker P., Jackson E., Kochanek P.M., Korbanik C. Fructose 1,6-biphosphate (FBP) by aortic arch flush (AAF) for cerebral preservation during 20 min exsanguination cardiac arrest (CA) in dogs: exploratory experiments. Acad. Emerg. Med. 6:1999;253. Abstract.
60. Behringer W., Prueckner S., Kentner R., Safar P., Radovsky A., Stezoski W., Henchir J., Tisherman S.A. Combination treatment of phenytoin and thiopental by aortic arch flush for cerebral preservation during 20 min exsanguination cardiac arrest (ExCA) in dogs: exploratory experiments. Crit. Care Med. 27:1999;A29. Abstract.
61. Behringer W., Prueckner S., Kentner R., Safar P., Radovsky A., Stezoski W., Wu X., Henchir J., Tisherman S.A. Exploration of pharmacologic aortic arch flush strategies for rapid induction of suspended animation (SA) (cerebral preservation) during exsanguination cardiac arrest (ExCA) of 20 min in dogs. Crit. Care Med. 27:1999;A65. Abstract.